@reytone_0001's Men's Health TRT claims, fact-checked
Quick answer
The transcript appears to reference alternative injection site locations, possibly for intramuscular or subcutaneous testosterone administration, but provides no clinical justification for neck or chin sites, which carry significant vascular and neurological risk. Standard TRT injection protocols supported by Endocrine Society guidelines recommend ventrogluteal, vastus lateralis, or deltoid sites for IM injection, and abdominal or gluteal subcutaneous tissue for subQ administration. Patients should consult their prescribing clinician before altering injection sites.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @reytone_0001 actually say?
Honestly, it's hard to know. The transcript gives us: "You'll have to do chest clap or neck clap or chin." That's it, repeated twice. There's no context, no explanation of what "clapping" refers to, and no connection made to TRT or testosterone therapy explicitly in the spoken words. The video was tagged under TRT content and credits Men's Health magazine, which gives us some directional clues, but the actual claim here is frustratingly opaque.
The most charitable read is that the creator is referencing injection site selection for testosterone cypionate or enanthate, where the chest (pectoral), neck, or chin area might be mentioned in some informal or fringe context. Another interpretation is that this refers to subcutaneous or intramuscular injection site alternatives. Without more audio or visual context, we're working with a fragment. We'll evaluate what we can, but this one required significant inference.
Does the science back this up?
If this is about injection sites, the short answer is: not for the neck or chin, and only marginally for the chest. The evidence base for TRT injection sites is pretty clear about where to go and where not to go.
Standard intramuscular injection sites for testosterone cypionate and enanthate include the ventrogluteal, vastus lateralis (outer thigh), and deltoid muscles. These are backed by clinical guidelines from the Endocrine Society (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism). Subcutaneous injection into abdominal or upper glute fat tissue has also gained traction, with Spratt et al. (2021, Andrology) demonstrating comparable bioavailability and patient-reported tolerability.
The neck and chin region? There is no peer-reviewed evidence supporting testosterone injections there. These areas carry serious neurovascular risk. The chest (pectoral region) is occasionally discussed in bodybuilding subcultures but is not a guideline-recommended site for medical TRT.
What did they get wrong (or right)?
If the creator is suggesting neck or chin as injection sites, that's wrong, and it could be genuinely dangerous. The neck contains the carotid artery, jugular vein, and multiple cranial nerve branches. Injecting anything near that region without clinical training is a serious risk for vascular injury, nerve damage, or systemic oil embolism. No legitimate TRT protocol recommends this.
To give credit where it's due: the chest (pectoral) has some informal use as a subcutaneous depot site, and a small number of clinical anecdotes exist. But it remains off-label, unstudied at scale, and not recommended by any major endocrinology body. If Men's Health published guidance pointing toward neck or chin injections, that would be a significant editorial failure on their part, and patients should not follow it.
The broader problem here is that social media TRT content, even when well-intentioned, compresses complex clinical decisions into 15-second clips with no room for safety nuance. That's a structural issue, not just a @reytone_0001 problem.
What should you actually know?
Injection site selection for TRT is a clinical decision, not a DIY experiment. Here's what the evidence actually supports:
- Ventrogluteal (hip) injections are considered the gold standard for intramuscular testosterone by most clinical protocols, due to lower risk of sciatic nerve proximity compared to the dorsogluteal site (Small, 2004, Journal of Advanced Nursing).
- Subcutaneous injections into abdominal fat or upper buttock tissue are increasingly used and have demonstrated comparable testosterone serum levels in multiple studies (Spratt et al., 2021, Andrology).
- Deltoid injections are acceptable for smaller volumes (0.5-1 mL) but carry more variability in absorption.
- Neck, chin, and face are never appropriate sites for self-administered testosterone injections. Period. No clinical evidence exists for this, and the anatomical risks are not theoretical.
- If you're on a regulated TRT protocol, your prescribing provider should be walking you through injection training. If they haven't, ask. If they refuse, find a different provider.
The Men's Health credit in the caption adds a layer of concern. Consumer fitness media is not a substitute for clinical guidance, and crediting a magazine for medical technique advice is a pattern worth being skeptical of.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 5 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @reytone_0001's Men's Health TRT claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@reytone_0001's Men's Health TRT claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The transcript appears to reference alternative injection site locations, possibly for intramuscular or subcutaneous testosterone administration, but provides no clinical justification for neck or chin sites, which carry significant vascular and neurological risk.
FormBlends verdict
The transcript appears to reference alternative injection site locations, possibly for intramuscular or subcutaneous testosterone administration, but provides no clinical justification for neck or chin sites, which carry significant vascular and neurological risk. Standard TRT injection protocols supported by Endocrine Society guidelines recommend ventrogluteal, vastus lateralis, or deltoid sites for IM injection, and abdominal or gluteal subcutaneous tissue for subQ administration. Patients should consult their prescribing clinician before altering injection sites.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The transcript appears to reference alternative injection site locations, possibly for intramuscular or subcutaneous testosterone administration, but provides no clinical justification for neck or chin sites, which carry significant vascular and neurological risk. Standard TRT injection protocols supported by Endocrine Society guidelines recommend ventrogluteal, vastus lateralis, or deltoid sites for IM injection, and abdominal or gluteal subcutaneous tissue for subQ administration. Patients should consult their prescribing clinician before altering injection sites.
- Endocrine Society guidelines (Bhasin et al., 2018, JCEM) name ventrogluteal, vastus lateralis, and deltoid as the accepted intramuscular testosterone injection sites, not chest, neck, or chin.
- Subcutaneous testosterone injections are supported by Spratt et al. (2021, Andrology), which found comparable serum testosterone levels versus IM, using abdominal or upper gluteal fat tissue only.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Endocrine Society guidelines (Bhasin et al., 2018, JCEM) name ventrogluteal, vastus lateralis, and deltoid as the accepted intramuscular testosterone injection sites, not chest, neck, or chin.
- Subcutaneous testosterone injections are supported by Spratt et al. (2021, Andrology), which found comparable serum testosterone levels versus IM, using abdominal or upper gluteal fat tissue only.
- Neck injections of any oil-based substance risk carotid artery damage, jugular vein injury, and oil embolism; no legitimate TRT protocol has ever recommended this site.
- The pectoral (chest) site has informal off-label use in some communities but has not been evaluated in controlled studies for testosterone pharmacokinetics or safety.
- Consumer fitness magazines, including Men's Health, are not appropriate sources for injection technique guidance on a regulated medication like testosterone cypionate or enanthate.
- Patients on self-injection TRT protocols should receive formal injection training from their prescribing clinician, including site selection, needle gauge, volume limits, and aspiration protocol.
- Social media TRT content lacks the clinical context needed to safely apply technique advice; a 15-second clip cannot convey anatomical contraindications or individual patient risk factors.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
sternocleidomastoid · TikTok creator
14.5K views on this video
thank you, once again Men's Health Mag #hudsonwilliams #fypシ゚viral #fyp #ineedhim #fyp
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by sternocleidomastoid, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.